As part of a major new strategic investment within the School of Life Sciences we are establishing a Translational Drug Discovery Group comprising medicinal chemistry and molecular pharmacology laboratories. This group will play a key role in the School’s translational research strategy, creating a vibrant collaboration across the chemical, biological and clinical sciences to translate the fundamental research discoveries within the University into potential new medicines.
The group aims to deliver drug candidates for evaluation in clinical trials by synthesising and characterising compounds with biological activity against defined molecular targets in indications such as cancer, neurodegenerative & psychiatric disease and pathogenic infection. We are initiating several early exploratory drug discovery programmes in parallel in collaboration with colleagues across the Schools of Life Sciences & Psychology, the Brighton and Sussex Medical School and the Royal Sussex and Brighton Hospital.
